Ownership history in SILVERARC CAPITAL MANAGEMENT, LLC Β· 12 quarters on record
This page tracks every 13F SEC filing in which SILVERARC CAPITAL MANAGEMENT, LLC reported a position in Tela Bio Inc (TELA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π SILVERARC CAPITAL MANAGEMENT, LLC underperformed the S&P 500 by β73.9% annually on this TELA position. Timing score: 18% (2/11 decisions correct). Average cost basis: $4.56. Maximum drawdown during holding period: β88.9%.
β Significantly underperformed the S&P 500 by 73.9% ann.
11 quarters analyzed
β οΈ Poor timing β buys often preceded drops, trims preceded rallies.
2 of 11 add/trim decisions correct
Best entry: $1.49 (2025 Q3) Β· Worst: $10.64 (2023 Q1)
πͺ Held through 1 major drawdown (>20%). Strong conviction under pressure.
9 adds Β· 3 trims. Bought during 6 of 9 down-price quarters. π Consistently bullish β fund kept accumulating this position.
π Portfolio weight has been declining in recent quarters. Possible distribution phase.
Currently 0.43% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size